Abstract
Sites targeted for contraception
Barrier method
Vas-based methods
Vasectomy
Reversible inhibition of sperm under guidance
Intra-vas device
Hormones, drugs, and herbs as contraceptives
Potential methods of contraception
According to World Health Organization (WHO) report, 122 million planned pregnancies occur each year worldwide. In addition to this, 87 million pregnancies are reported to be unintended, and 46 million pregnancies are terminated medically (WHO2005). Surprisingly, in 50% of unintended pregnancies, some contraceptive measures are used. This shows convincing failure rate of available contraceptives. While there are numerous forms of contraception available, it is clear that there is no single method which fulfills the requirement of an ideal contraceptive. It is estimated that male contraceptives account for 37% of all contraceptive measures. Currently, among all available male contraceptives, condoms, abstinence, withdrawal, and vasectomy are believed to be successful. However, these methods are reported to be unpleasant, doubtful, and unacceptable for many users. The requirement of a safe, effective, and reversible male contraception is, thus, an essential requirement.
This is a preview of subscription content,log in via an institution to check access.
Access this chapter
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
- Chapter
- JPY 3498
- Price includes VAT (Japan)
- eBook
- JPY 10295
- Price includes VAT (Japan)
- Softcover Book
- JPY 12869
- Price includes VAT (Japan)
- Hardcover Book
- JPY 18589
- Price includes VAT (Japan)
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Amory JK, Muller CH, Page ST, Leifke E, Pagel ER, Bhandari A, et al. Miglustat has no apparent effect on spermatogenesis in normal men. Hum Reprod. 2007;22(3):702–7.
Ansari AS, Hussain M, Khan SR, Lohiya NK. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception. Andrology. 2016;4(2):306–13.
Aston KI, Krausz C, Laface I, Ruiz-Castané E, Carrell DT. Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent. Hum Reprod. 2010;25(6):1383–97.
Babcock DF. Wrath of the wraiths of CatSper3 and CatSper4. Proc Natl Acad Sci U S A. 2007;104(4):1107–8.
Behre HM, Nashan D, Hubert W, Nieschlag E. Depot gonadotrophin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab. 1992;74(1):84–90.
Benoff S, Cooper GW, Hurley I, Mandel FS, Rosenfeld DL, Scholl GM, et al. The effect of calcium ion channel blockers on sperm fertilization potential. Fertil Steril. 1994;62(3):606–17.
Chen ZD, Liu JD, Kong ZL, Huang YZ, Jiang RG, Ren FJ, et al. Clinical studies on therapeutical efficacy of TU in the treatment of patients with sexual dysfunction and male infertility. J Zhejiang Med Univ. 1991;20:126–9.
Chen ZL, Huang XB, Suo JP, Li J, Sun L. The contraceptive effect of a novel filtering-type nano-copper complex/polymer composites intra-vas device on male animals. Int J Androl. 2010;33(6):810–7.
Cheng CY, Silvestrini B, Grima J, Mo MY, Zhu LJ, Johansson E, et al. Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis. Biol Reprod. 2001;65(2):449–61.
Cilip CM, Allaf ME, Fried NM. Application of optical coherence tomography and high-frequency ultrasound imaging during noninvasive laser vasectomy. J Biomed Opt. 2012;17(4):046006-1-5.
Cook CE, Kepler JA. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties. Bioorg Med Chem Lett. 2005;15(4):1213–6.
Coulston F, Dougherty WJ, LeFevre R, Abraham R, Silvestrini B. Reversible inhibition of spermatogenesis in rats and monkeys with a new class of indazole-carboxylic acids. Exp Mol Pathol. 1975;23:357–66.
De Martino C, Malcorni W, Bellocci M, Floridi A, Marcante ML. Effects of AF 1312 TS and lonidamine on mammalian testis. A morphological study. Chemotherapy. 1981;27 Suppl 2:27–42.
Fu J, Wang Y, Fok KL, Yang D, Qiu Y, Chan HC, et al. Anti-ACTL7a antibodies: a cause of infertility. Fertil Steril. 2012;97(5):1226–33.
Guha SK. Contraceptive for use by a male US. 1996; Patent 54880705.
Hasenack HG, Bosch AM, Käär K. Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel. Contraception. 1986;33(6):591–6.
Hild SA, Reel JR, Dykstra MJ, Mann PC, Marshall GR. Acute adverse effects of indenopyridine, CDB-4022, on the ultrastructure of Sertoli cells, spermatocytes and spermatids in rat testes: comparison to the known Sertoli cell toxicant, di-n-pentylphthalate (DPP). J Androl. 2007;28(4):621–9.
Johnston DS, Jelinsky SA, Bang HJ, DiCandeloro P, Wilson E, Kopf GS, et al. The mouse epididymal transcriptome: transcriptional profiling of segmental gene expression in the epididymis. Biol Reprod. 2005;73(3):404–13.
Kapur MM, Mokkapati S, Farooq A, Ahsan RK, Laumas KR. Copper intravas device (IVD) and male contraception. Contraception. 1984;29(1):45–54.
Kinniburgh D, Zhu H, Cheng L, Kicman AT, Baird DT, Anderson RA. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men. Hum Reprod. 2002;17:1490–501.
Kumar S, Chaudhury K, Sen P, Guha SK. Quantitative analysis of surface micro-roughness alteration in human spermatozoa using atomic force microscopy. J Microsc. 2007;227(Pt 2):118–23.
Li H, Ding X, Guo C, Guan H, Xiong C. Immunization of male mice with B-cell epitopes in transmembrane domains of CatSper1 inhibits fertility. Fertil Steril. 2012;97(2):445–52.
Li MH, Guo SB, Fang RY, Zhang YP. Pharmacological and clinical effects of testosterone undecanoate. N Drugs Clin Remedies. 1994;13:279–81.
Lohiya NK, Goyal RB. Antifertility investigation on the crude chloroform extract of Carica papaya Linn. Seeds in male albino rats. Indian J Exp Biol. 1992;30:1051–5.
Lohiya NK, Suthar R, Khandelwal A, Goyal S, Ansari AS, Manivannan B. Sperm characteristics and teratology in rats following vas occlusion with RISUG® and its reversal. Int J Androl. 2010;33(1):e198–206.
Mdhluli MC, van der Horst G. The effect of oleanolic acid on sperm motion characteristics and fertility of male Wistar rats. Lab Anim. 2002;36(4):432–7.
O’Rand MG, Widgren EE, Wang Z, Richardson RT. Eppin: an epididymal protease inhibitor and a target for male contraception. Soc Reprod Fertil Suppl. 2007;63:445–53.
Panneerdoss S. Preclinical investigation on the contraceptive efficacy and toxicological evaluation of the Carica papaya seed product in langur monkey Presbytis entellus entellus, PhD. Thesis, University of Rajasthan, Jaipur. 2004.
Qian SZ, Hu JH, Ho LX, Sun MX, Huang YZ, Fang JH. The first clinical trail of gossypol on male. In: Turner P, editor. Clinical pharmacology and therapeutics. Proceeding of first world conference on Clinical Pharmacology & Therapeutics, McMillan; 1972. p. 489–492.
Qian SZ, Zhong CQ, Xu N, Xu Y. Antifertility effect of Tripterygium wilfordii in men. Adv Contracept. 1986;2:253–4.
Qian SZ, Xu Y, Zhang JW. Recent progress in research on Tripterygium: a male antifertility plant. Contraception. 1995;51:121–9.
Rajasekaran M, Bapna JS, Lakshmanan S, Ramachandran Nair AG, Veliath AJ, Panchanadam M. Antifertility effect in male rats of oleanolic acid, a triterpene from Eugenia jambolana flowers. J Ethnopharmacol. 1988;24(1):115–21.
Reel JR, Humphrey RR, Shih YH, Windsor BL, Sakowski R, Creger PL, et al. Competitive progesterone antagonists: receptor binding and biologic activity of testosterone and 19-nortestosterone derivatives. Fertil Steril. 1979;31(5):552–61.
Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Tweedy KG. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. JAMA. 2002;287(9):1117–22.
Shang E, Nickerson HD, Wen D, Wang X, Wolgemuth DJ. The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation. Development. 2007;134(19):3507–15.
Sharlip ID. What is the best pregnancy rate that may be expected from vasectomy reversal? J Urol. 1993;149:1469–71.
Suganuma R, Walden CM, Butters TD, Platt FM, Dwek RA, Yanagimachi R, et al. Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities. Biol Reprod. 2005;72(4):805–13.
van der Spoel AC, Jeyakumar M, Butters TD, Charlton HM, Moore HD, Dwek RA, et al. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc Natl Acad Sci U S A. 2002;99(26):17173–8.
Vyas DK, Jacob D. Effect of Papaya (Carica papaya) seeds on the reproductive structure and fertility of the male rabbits. Indian Zool. 1984;8:105–8.
Weigel Muñoz M, Ernesto JI, Bluguermann C, Busso D, Battistone MA, Cohen DJ, et al. Evaluation of testicular sperm CRISP2 as a potential target for contraception. J Androl. 2012;33(6):1360–70.
World Health Organization. The World Health Report 2005: Make every mother and child count. Geneva; 2005: 243.
Wu FCW, Balasubramanian R, Mulders TMT, Coelingh-Bennink HJT. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab. 1999;84:112–22.
Yang ZJ, Ye WS, Cui GH, Guo Y, Xue SP. Combined administration of low dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men. Contraception. 2004;70:203–11.
Author information
Authors and Affiliations
Centre for Advanced Studies, Department of Zoology, University of Rajasthan, Jaipur, 302004, India
N. K. Lohiya PhD, FNASc, FAMS, FIAES, FEMSI, Imtiyaz Alam MSc & A. S. Ansari PhD
- N. K. Lohiya PhD, FNASc, FAMS, FIAES, FEMSI
You can also search for this author inPubMed Google Scholar
- Imtiyaz Alam MSc
You can also search for this author inPubMed Google Scholar
- A. S. Ansari PhD
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toN. K. Lohiya PhD, FNASc, FAMS, FIAES, FEMSI.
Editor information
Editors and Affiliations
Department of Reproductive Biology, All India Institute of Medical Sciences, New Delhi, India
Anand Kumar
Department of Reproductive Biology, All India Institute of Medical Sciences, New Delhi, India
Mona Sharma
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lohiya, N.K., Alam, I., Ansari, A.S. (2017). Male Contraception. In: Kumar, A., Sharma, M. (eds) Basics of Human Andrology. Springer, Singapore. https://doi.org/10.1007/978-981-10-3695-8_29
Download citation
Published:
Publisher Name:Springer, Singapore
Print ISBN:978-981-10-3694-1
Online ISBN:978-981-10-3695-8
eBook Packages:Biomedical and Life SciencesBiomedical and Life Sciences (R0)
Share this chapter
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative